Streetbeat News

Revenues

IBIT

The top four ETF launches in 2024 are all spot Bitcoin ETFs, with BlackRock's iShares Bitcoin ETF (NASDAQ:IBIT) leading the pack with $20.5 billion in assets under management. Despite Schwab being a major ETF issuer, it has yet to launch a spot Bitcoin ETF. Institutional adoption of Bitcoin ETFs is expected to increase, with Morgan Stanley allowing advisors to pitch Bitcoin ETFs to high-risk clients.

Portfolio Pulse from Khyathi Dalal

August 14, 2024 | 3:18 pm

SXTP

60 Degrees (NASDAQ:SXTP) reported Q2 EPS of $(4.23), a significant improvement from $(16.84) YoY. Sales increased by 109.92% to $124.97K from $59.53K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 3:15 pm

EWCZ

European Wax Center shares are trading lower after the company reported worse-than-expected Q2 sales results and lowered its FY24 revenue guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 3:11 pm

DHC

IRT

NHI

REZ

UMH

WELL

Mortgage applications surged by 16.8% in the week ending Aug. 9, marking the largest one-week jump since January 2023. This increase, despite stable interest rates, led to a significant rise in refinance activity and positively impacted mortgage-linked stocks, including the iShares Residential and Multisector Real Estate ETF (REZ) and its top-performing stocks.

Portfolio Pulse from Piero Cingari

August 14, 2024 | 3:07 pm

EWCZ

European Wax Center has lowered its FY24 revenue guidance from $225M-$232M to $216M-$221M, below the $230.74M estimate. The company also revised its outlook for new center openings, system-wide sales, same-store sales, adjusted net income, and adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 3:07 pm

AZN

AstraZeneca is reconsidering its $578.4 million investment in a new vaccine-manufacturing site in the UK due to a reduction in government funding. The UK Treasury has cut its support from 65 million pounds to around 40 million pounds, leading AstraZeneca to consider relocating the project to France. This decision could impact the company's vaccine manufacturing expansion plans.

Portfolio Pulse from Vandana Singh

August 14, 2024 | 3:04 pm

EWCZ

European Wax Center (NASDAQ:EWCZ) reported Q2 sales of $59.87 million, missing the analyst consensus estimate of $61.33 million by 2.38%. This represents a 1.32% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 3:03 pm

MCD

McDonald's (NYSE:MCD) has outperformed the market over the past 20 years with an average annual return of 12.27%, significantly boosting investor returns through compounded growth. A $100 investment in MCD 20 years ago would be worth $996.25 today.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 3:02 pm

ADNT

Over the past three months, analysts have provided mixed ratings for Adient (NYSE:ADNT), with a recent trend towards more bearish sentiments. The average 12-month price target has decreased by 13.08% to $28.1. Analysts from firms like Morgan Stanley, JP Morgan, Barclays, UBS, and B of A Securities have lowered their price targets and ratings, reflecting concerns over Adient's financial performance, including declining revenue, low net margins, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 3:01 pm

CRWD

MSFT

NOW

ORCL

PANW

The article provides a comprehensive comparison of ServiceNow (NYSE:NOW) against its key competitors in the software industry, focusing on financial metrics, market position, and growth prospects. Key takeaways include ServiceNow's high PE ratio, low PB ratio, high PS ratio, low ROE, low EBITDA, low gross profit, and high revenue growth rate. The company also has a favorable debt-to-equity ratio compared to its top peers.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 3:00 pm